Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunohistochemical Expression and Prognostic Significance of ALDOA in Bladder Urothelial Carcinoma.

NCT06550947 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06550947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06550947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunohistochemical Expression and Prognostic Significance of ALDOA in Bladder Urothelial Carcinoma.
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
August 31, 2025
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder urothelial carcinoma